190 filings
20-F
2023 FY
CVAC
CureVac N.V.
Annual report (foreign)
24 Apr 24
5:39pm
6-K
CVAC
CureVac N.V.
24 Apr 24
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
4:30pm
6-K
CVAC
CureVac N.V.
24 Apr 24
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
4:20pm
6-K
CVAC
CureVac N.V.
24 Apr 24
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
4:15pm
6-K
CVAC
CureVac N.V.
16 Apr 24
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
4:15pm
144
Greune Malte
12 Apr 24
Notice of proposed sale of securities
4:48pm
6-K
CVAC
CureVac N.V.
4 Apr 24
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
4:15pm
SC 13G/A
Ra Capital Management, LLC
14 Feb 24
CureVac / RA CAPITAL MANAGEMENT ownership change
5:01pm
SC 13G/A
CVAC
CureVac N.V.
6 Feb 24
CureVac / GSK ownership change
5:10pm
6-K
CVAC
CureVac N.V.
17 Jan 24
CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock
9:02am
6-K
CVAC
CureVac N.V.
5 Jan 24
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development
4:15pm
144
Mendila Myriam
5 Jan 24
Notice of proposed sale of securities
3:19pm
144
CVAC
CureVac N.V.
5 Jan 24
Notice of proposed sale of securities
3:09pm
144
Greune Malte
5 Jan 24
Notice of proposed sale of securities
2:57pm
144
Kemula Pierre
5 Jan 24
Notice of proposed sale of securities
2:41pm
6-K
CVAC
CureVac N.V.
19 Dec 23
CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
4:30pm
6-K
CVAC
CureVac N.V.
14 Nov 23
Current report (foreign)
4:15pm
6-K
CVAC
CureVac N.V.
14 Nov 23
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
4:15pm
6-K
CVAC
CureVac N.V.
1 Nov 23
CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK
4:45pm
UPLOAD
CVAC
CureVac N.V.
19 Oct 23
Letter from SEC
12:00am